Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492479 · ClinicalTrials.gov registry record · Phase 4
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
A Phase 4 study, sponsored by Innovative Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00492479: Clinical Trial Phase 4 study, sponsored by Innovative Medical.
NCT00492479 is a Phase 4 study that was terminated before completion, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00492479, a Phase 4 study, was terminated before completion, sponsored by Innovative Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
Interventions
- DRUG Kinerase Pro+Therapy Line day repair, serum, night repair
- DRUG Kinerase Pro+Therapy Line Ultra rich day repair
- DRUG LubriDerm
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Why NCT00492479 stopped before completion
NCT00492479 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Kinerase Pro+Therapy Line day repair, serum, night repair is the first listed.
NCT00492479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00492479 about?
NCT00492479 is a clinical study titled "An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging". The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
What is the current status of trial NCT00492479?
This trial is currently terminated. It is a Phase 4 study. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00492479?
The interventions under investigation include: Kinerase Pro+Therapy Line day repair, serum, night repair (DRUG), Kinerase Pro+Therapy Line Ultra rich day repair (DRUG), LubriDerm (DRUG).
Who is sponsoring clinical trial NCT00492479?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia